GGrantIndex
Sort

39,280 grants matching leukemia

Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity

$778,829
Eliver Ghosn · Emory University · R01 · FY2025 · AI

Simple and Effective Method for Cell Separation During Preclinical Research and Cell Therapy Manufacturing

$778,695
Bob Snyder · Proteios Technology, Inc. · R44 · FY2023 · GM

COG NCTN Network Group Operations Center

$778,576
Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2015 · CA

Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector

$778,478
David A Williams · Boston Children'S Hospital · U01 · FY2021 · AI

Low-Cost Digital Gene Expression System

$778,007
Steven Jeffrey Gordon · Intelligent Bio-Systems, Inc. · R44 · FY2013 · CA

Senior Leaders

$777,779
Judith Cheryl Gasson · University Of California Los Angeles · P30 · FY2010 · CA

Preventing GVHD by inhibition of alloantigen presentation in the gut

$777,776
Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2022 · HL

Mitigating radiodermatitis by blocking IL-1-dependent neutrophilic inflammation

$777,191
Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · RC1 · FY2008 · AI

Gene Therapy in Hematopoietic Cells

$777,107
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2010 · HL

Engineering T cells to Promote Islet Transplant

$776,922
James L Riley · University Of Pennsylvania · R01 · FY2023 · DK

MicroRNAs and hematopoietic differentiation

$776,392
Whitehead Institute For Biomedical Res · R01 · FY2004 · DK

HDAC Inhibition to prevent GVHD

$776,379
Pavan Reddy · University Of Michigan At Ann Arbor · P01 · FY2011 · CA

FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS

$776,255
Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2017 · HL

New retroviral restriction factor

$776,245
Tatyana V. Golovkina · University Of Chicago · R56 · FY2021 · AI

Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting

$776,201
Ulrich Steidl · Albert Einstein College Of Medicine · R35 · FY2021 · CA

Heartland Cancer Research CCOP

$776,180
Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2008 · CA

DNMT3A in Development of Hematologic Malignancies

$776,000
Margaret Goodell · Baylor College Of Medicine · R01 · FY2025 · CA

Mechanisms of nonsense-mediated mRNA decay target selection

$775,945
John Hogg · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Original Phase 1 Title: Identifying Small Molecule Inhibitors of HdmX using Cell-based Screening Revised Title: Development of a Novel HdmX Inhibitor for Leukemia

$775,796
Mukesh Kumar Agarwal · Invenio Therapeutics, Inc. · R44 · FY2015 · CA

Hematopoietic Stem Cells for Transplantation

$775,678
Curt I Civin · Johns Hopkins University · P01 · FY2007 · CA

Core C - Sequencing and Analysis.

$775,609
Christopher A Miller · Washington University · P01 · FY2023 · CA

BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma

$775,192
Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA

CyTOF Mass Cytometer for Western New York

$775,000
Timothy P Bushnell · University Of Rochester · S10 · FY2012 · OD

Collaborative Human Tissue Network (CHTN)

$774,914
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · UM1 · FY2016 · CA

Collaborative Human Tissue Network (CHTN)

$774,914
Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · UM1 · FY2015 · CA